Bird & Bird advised Biomemory on its €17 million fundraising round

Published

Dec 23 2024

Related

Practices

Sectors

Countries

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol. 

News & Deals

More News & Deals
Deal Bird & Bird advises Ryde Group on Strategic EV Investment in Atoll Discovery

Aug 19 2025

Read More
Deal Bird & Bird advises MyRepublic on Strategic Broadband Sale to StarHub

Aug 15 2025

Read More
Deal Bird & Bird advises Theon on the acquisition of Kappa Optronics

Aug 12 2025

Read More
Deal Bird & Bird advises shareholders of The Payments Association on partnership with Nineteen Group

Aug 07 2025

Read More
Deal Bird & Bird acts for Cornerstone Investors in US$140m placing by Rockhopper Exploration

Aug 06 2025

Read More
News Bird & Bird boosts Dispute Resolution team in Singapore

Aug 06 2025

Read More
More News & Deals

Related capabilities

Corporate Venture Capital Technology & Communications Life Sciences and Healthcare